Direct emissions
368,733
tCO2e
O
Otsuka Pharmaceutical Europe LTD.
Explore carbon emissions data for Otsuka Pharmaceutical Europe LTD.. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.
This profile brings together available carbon emissions data for Otsuka Pharmaceutical Europe LTD., including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. Read how we source and check this data.
Emissions
Carbon emissions
Total yearly emissions across all scopes
1,425,122 tCO2e (Market Based)
Scope 1
tCO2e
368,733
Scope 2 (Market Based)
tCO2e
747
Scope 3 total
tCO2e
1,055,642
Scope 3 reported
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
Provenance
Emissions
Factors
4,371,110
kgCO2e / £M
Supplier specific emission factors (kgCO2e / £M)
Modelled
Reported
Scope 1 + 2
Direct + purchased energy
1,133,263
1,133,263
Upstream
+ upstream Scope 3
3,975,222
3,975,222
Total
+ all Scope 3
4,371,110
4,371,110
Which figure should I use?
Use Modelled. It is the most complete view: any categories the company hasn't disclosed are filled with industry-typical estimates, so a transparent company isn't unfairly penalised against one that simply hasn't reported.
Reported counts only emissions the company has filed itself. A blank or low Reported cell doesn't mean those emissions don't exist, just that the company hasn't disclosed them.
When Reported sits close to Modelled, that is a positive signal. The company has disclosed most of its salient emissions and there's little gap for the model to fill. Even then, Modelled is the right figure to use for a like-for-like comparison across companies.
Sustainability
Snapshot
Based on reported data, retrieved with AI
- Otsuka Pharmaceutical Europe LTD. reported 1,425,122 tCO₂e in 2024.
- Scope 3 accounted for 74% of emissions.
- Reported across 15 of 15 GHG Protocol Scope 3 categories.
- Scope 2 reported under the market based methodology.
According to available emissions disclosures, Otsuka Pharmaceutical Europe LTD. reported total yearly emissions of 1,425,122 tCO₂e in 2024. Scope 3 emissions accounted for 74% of reported output, indicating supply chain activity, purchased goods and services, business travel, and wider operational dependencies were the most significant contributors to the company's carbon footprint.
The company achieved a Mycelium Score of 1.7, placing it well below average for its sector for sustainability performance, and received a transparency score of 100.0, an exceptional result, reflecting open disclosure across nearly every key emissions metric.
Total Emissions across all scopes
1,425,122 tCO2e (Market Based)
Scope 1 emissions
Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.
Scope 2 emissions
Indirect emissions from purchased energy, including electricity, heating and cooling.
Location based
101,046
tCO2eMarket based
747
tCO2eScope 3 emissions
Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.
Cat 1
Purchased goods & services
698,157
tCO2eCat 2
Capital goods
82,447
tCO2eCat 3
Fuel & energy related activities
35,448
tCO2eCat 4
Upstream transportation & distribution
72,476
tCO2eCat 5
Waste generated in operations
12,233
tCO2eCat 6
Business travel
13,354
tCO2eCat 7
Employee commuting
6,105
tCO2eCat 8
Upstream leased assets
6,350
tCO2eCat 9
Downstream transportation & distribution
21,373
tCO2eCat 10
Processing of sold products
2
tCO2eCat 11
Use of sold products
85,894
tCO2eCat 12
End-of-life treatment of sold products
21,797
tCO2eCat 13
Downstream leased assets
2
tCO2eCat 14
Franchises
2
tCO2eCat 15
Investments
2
tCO2eContact Info
Website
www.otsuka-europe.comAddress
2
Windsor Dials
Arthur Road
Windsor
Berkshire
SL4 1RS
Country
United Kingdom
Phone
+44 20 8756 3100Browse carbon emissions data by industry
Jump straight into the sectors users explore most, or view all industries.
How scoring works
How the Mycelium Score is calculated
The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue). The remaining 3.5 reflect data quality: third-party verified, profile claimed by the company, and full disclosure across all reporting categories.
A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Otsuka Pharmaceutical Europe LTD.'s score sits at the top of this page and in the score panel.
How the Transparency Score is calculated
The Transparency Score measures how much of a company's key emissions data is publicly disclosed, graded from A (very high) down to F (very low). Crucially, it weights each gap by how material that bucket is for the company's industry, so an undisclosed category where the bulk of emissions sit hurts far more than a minor one.
Otsuka Pharmaceutical Europe LTD. has disclosed the emissions categories that are material for its industry, so there's no single bucket dragging the transparency score down. The breakdown above shows full coverage across the categories that matter most for this kind of company.
Read the full scoring methodology
Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10.
Download the white paper (PDF)
Otsuka Pharmaceutical Europe LTD. carbon emissions FAQs
What are Otsuka Pharmaceutical Europe LTD.'s carbon emissions?
In its 2024 reporting year, Otsuka Pharmaceutical Europe LTD. disclosed total emissions of 1,425,122 tCO2e across all scopes. Scope 3 accounted for the largest share, around 74% of the total.
Does Otsuka Pharmaceutical Europe LTD. report Scope 1, Scope 2 and Scope 3 emissions?
For 2024, Otsuka Pharmaceutical Europe LTD.'s available disclosure covers Scope 1 (368,733 tCO2e), Scope 2 (747 tCO2e), Scope 3 across 15 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.
How transparent is Otsuka Pharmaceutical Europe LTD.'s emissions reporting?
Otsuka Pharmaceutical Europe LTD. has a Mycelium transparency score of 100 out of 100. The score weights each emissions category by how material it is for the company's industry, so it reflects whether the disclosures that matter most have been made.
Is Otsuka Pharmaceutical Europe LTD. sustainable?
Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Otsuka Pharmaceutical Europe LTD. has a Mycelium Score of 1.7 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.
Is Otsuka Pharmaceutical Europe LTD. environmentally friendly?
Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Otsuka Pharmaceutical Europe LTD. disclosed 1,425,122 tCO2e for 2024, and its Mycelium Score of 1.7 out of 10 shows how that performance compares with similar companies in its sector.
Learn more about our methodology and where this data comes from.
